SUSMED,Inc.

¥276.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4263Healthcare
Country Japan
PE (Fwd) •••
TSR 5Y CAGR (34.26%)
Div yield —
ROE (11.43%)
Biotechnology
Beta (5Y) 1.17
PE TTM —
TSR TTM (69.80%)
Mkt cap ¥4.640B
ROIC (3.98%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥265
(4.06%)
(29.03%)
Hold 6|10|11|11|4
2Q26
3Q26
4Q26
1Q27
Earnings per share¥
3.33
3.63
4.06
4.36
27.92%
25.98%
32.86%
42.37%
Revenue¥M
403.7
398.8
403.0
396.1
16.01%
10.67%
8.21%
2.43%
Peers (US$29.46M)
Cap (US$)
PE
32.55M
24.18x
Capital
TTM
5Y
10Y
Leveragex
0.888
0.060
0.063
EBIT/Intx
0.871
0.719
0.669
Own earn%
(9.59)
67.44
52.70
Sh yield%
14.52
37.15
36.70
Owners
Insiders/Inst%
8.24
55.07
Short interest%
2.88
SBC / revenue%
3.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
24–29
$1 testx
−0.2
Incr. ROIC%
3